RAC 2.92% $1.94 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-301

  1. 279 Posts.
    lightbulb Created with Sketch. 38
    I just finished the 90 min YT video of the presentation. Super impressed by the way it was run, in fact the swiftly moving Pete from the preso straight into another meeting just shows the commitment of the current management team.
    yes timelines moved out but RC220 will deliver more value for shareholders. The data package is being built with FDA fast-tracking in mind
    Ideally, this ends up in a bidding war one day. Who knows.
    I believe in DT & the team.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.